Blue Origin's rocket reuse achievement marred by upper stage failure
Quick Insights
The Bottom Line
Blue Origin's rocket reuse success was overshadowed by an upper stage failure.
AI Summary
Blue Origin's New Glenn launcher achieved its first successful reflight of an orbital-class booster on Sunday, but the flight ended with a setback for the rocket's upper stage. The 321-foot-tall New Glenn launch vehicle ignited its seven methane-fueled BE-4 engines at 7:25 am EDT from Cape Canaveral Space Force Station, Florida. Three minutes into the flight, the booster separated after accelerating the rocket past the speed of sound. This event marks a partial success for the heavy-lift launcher, which is a key element in NASA's Artemis lunar program. The article indicates the upper stage experienced a failure after booster separation.
Source Coverage Map
2 of 43 tracked sources covered this story
Following this story?
Get notified when new coverage appears
Other Sources Covering This Story
1 sourceMultiple outlets have reported on this story. Compare perspectives from different sources.
This article is part of a story we're tracking:
Should this be getting more attention?
You Might Have Missed
Related stories from different sources and perspectives
CorporateBlue Origin's New Glenn rocket grounded after launching satellite into wrong orbit
Jeff Bezos' rocket company, Blue Origin, blamed a bad engine Monday for a failed weekend launch that left a satellite in the wrong orbit, dooming it.
TechnologyBlue Origin’s New Glenn rocket is grounded after launching satellite into the wrong orbit - AP News
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxNdXpMOGhGMnJPbFg4Q3JNZWJfVnhfaFJJTHhLWTY2Wk9xVmpSblE1elprR21iUm55QWMyQjNSRF9xVVhzTE9XS1MyMDRnYUNkZVBwM2l0Y2NYeFJGWEc3SHhNei1WMjFldUlhbWpvdkY5RnNfMDlNY3I5Vm5xbWhheTQza1AyeFIzbVFOZ3NpTEFjUWRQVGhRa0hLbw?oc=5" target="_blank">Blue Origin’s New Glenn rocket is grounded after launching satellite into the wrong orbit</a> <font color="#6f6f6f">AP News</font>
PoliticsPaxton alleges ActBlue misled Congress, public about donation vetting
Texas Attorney General Ken Paxton has sued ActBlue, alleging that the major Democratic Party fundraising platform misled Congress and the public about its donation processes. “ActBlue lied to Congress and to the American people, and I will ensure justice is served. It has blatantly ignored state law that prohibits deceptive practices, and it must pay…
HealthExperimental pancreatic cancer pill helps improve survival in late-stage study
Revolution Medicines' experimental oral drug helped patients with pancreatic cancer live longer and showed an improvement in survival without worsening of the disease in a keenly anticipated late-stage trial. Patients who received the once-daily pill, daraxonrasib, showed a median overall survival of 13.2 months compared with 6.7 months for those who were given intravenous cytotoxic chemotherapy, the standard of care, the company said on Monday.

Eddie Murphy receives life achievement award by AFI, drawing standing ovation at star-filled tribute - AP News
<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxQOGtMWjdUMVRRMldwdUp5cVBOTkwxYWRKengyV1lucGM3YmRIbUFkeS02MGJHNDNlTUhqSVVTeS1TS2h6SVJoTDFmak1XVzViV1I1a2tVYVhpUUwyajdGbEtqUzdiMHF5Q3Etd3lNcVBNdm02QmZETnFSY3ZoSlAwc29n?oc=5" target="_blank">Eddie Murphy receives life achievement award by AFI, drawing standing ovation at star-filled tribute</a> <font color="#6f6f6f">AP News</font>
Civil RightsFamilies left reeling after hospitals in blue states drop transgender care for youth
Massachusetts passed laws and joined lawsuits to protect access to gender-affirming care for minors. But faced with the Trump administration's threats, some hospitals voluntarily stopped care.

Florida Opens Criminal Inquiry Into ChatGPT Tied to Fatal School Shooting - The New York Times
Did this story change how you see things?
Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.
The Verity Ledger curates verified investigative journalism from trusted sources only.
See our sourcesMost Read This Week
Report: Merck’s blockbuster cancer drug topped $200,000 a year under Trump

White House ramps up pressure to pass crypto bill as Congress returns

One in three Americans forced to make financial sacrifices for health coverage

Tanzania investigates death of American social media influencer - Reuters

Airline mega-merger story is all about Trump



